
    
      This is a companion study to the protocol SCB01A-01 intended to provide long-term continued
      administration to subjects that completed Protocol SCB01A-01 on a compassionate basis. It is
      an open-label, single-arm study of SCB01A in subjects who have completed at least one cycles
      of treatment under the SCB01A-01 protocol.
    
  